| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.006 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.007 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |